Engineering knockout of sirtuin-1 in podocytes, a known antagonist of STAT3, increased acetylation of p65 and STAT3, making the mice more responsive to DN [52], emphasizing the detrimental effects of activated STAT3 on the occurrence of DN. This evidence concerns the gene STAT3 and liver dysplastic nodule.